Rong Hou

AbbVie

Rong Hou is Regulatory Affairs Associate Director in China Regulatory Affairs at AbbVie, mainly responsible for drug regulatory projects as well as regulatory intelligence in China. Before joining AbbVie, Rong spent over ten years holding positions in drug regulatory affairs at Novartis, Ferring and GlaxoSmithKline, covering the therapeutic areas of respiratory, cardiovascular diseases, and women’s health. Rong earned a Master’s degree in Applied Chemistry from Beijing University of Chemical Technology.

iSpeak Blog

China’s Regulatory Framework for Combination Products: Ongoing Challenges and Potential Opportunities

4 August 2022

As the world’s second largest market for pharmaceuticals and accounting for 20% of global medical device sales with double digit annual growth, the Chinese market is poised to have a significant impact on expanding patient access to innovative therapies and combination products (CPs).

Rong Hou

Related Articles